IP Verse

Von Kauffmann patent opposition analysis

The comprehensive analysis of Von Kauffmann opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Von Kauffmann

Stay updated with the latest patent oppositions filed by Von Kauffmann

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3242666
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 16, 2025TEVA PHARMACEUTICALS
EP3801459
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 7, 2025TEVA PHARMACEUTICALS
EP3582814
Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal ManifestationsARENA PHARMACEUTICALSFeb 1, 2025TEVA PHARMACEUTICALS
EP3529360
Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionTHE MEDICINESJan 17, 2025TEVA PHARMACEUTICALS
EP3565542
Polymorphic Forms Of Rad1901-2HclRADIUS PHARMACEUTICALSJan 10, 2025TEVA PHARMACEUTICALS
EP2395968
Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 16, 2024TEVA PHARMACEUTICALS
EP3265084
Pharmaceutical Formulations Of Bruton'S Tyrosine Kinase InhibtorPHARMACYCLICSAug 21, 2024TEVA PHARMACEUTICALS
EP3999643
Methods Of Treating Or Preventing Spinal Muscular AtrophyBIOGEN MAAug 21, 2024TEVA PHARMACEUTICALS
EP3846810
Chronic Nightly Dosing Of Lasmiditan For Migraine PreventionELI LILLYJul 15, 2024TEVA PHARMACEUTICALS
EP3110449
Medical Use Of A Dpp-4 InhibitorBOEHRINGER INGELHEIMMar 21, 2024TEVA PHARMACEUTICALS

Top clients of Von Kauffmann

Top companies who are the clients of Von Kauffmann

CompanyTotal
TEVA PHARMACEUTICALS20